Meyer, A., Horton, D., Neugebauer, N., Wooters, T., , Dwoskin, L., & Bardo, M. (2011). Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration. Neuropharmacology, 61(4), 849-56. https://doi.org/10.1016/j.neuropharm.2011.05.033

Beckmann, J., Siripurapu, K., , Horton, D., Denehy, E., Vartak, A., … Bardo, M. (2010). The novel pyrrolidine nor-lobelane analog UKCP-110 cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats. The Journal of Pharmacology and Experimental Therapeutics, 335(3), 841-51. https://doi.org/10.1124/jpet.110.172742

Lee, N., Zheng, G., Leggas, M., , , Crooks, P., … Dwoskin, L. (2019). GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine. The Journal of Pharmacology and Experimental Therapeutics, 371(2), 526-543. https://doi.org/10.1124/jpet.119.258699